Gujarat Themis Biosyn's board approved Q3 financial results, reporting a net profit of ₹12.46 Cr. The board also re-appointed Ms. Kirandeep Madan as Independent Director for a second term and appointed Mr. Krupesh Patel as the new CFO from April 1, 2026.